Abstract
Small interfering RNAs (siRNA) have enabled novel, specific, and efficient treatment of diseases, including cancer. To obtain sufficient and well-controlled intracellular delivery, a drug delivery system is essential. Herein a delivery system for siRNA, composed of cationic biodegradable nanogels, is presented. p(DEAEMA-co-HEMA-g-PEGMA) nanogels with varying ratios of 2-diethyl aminoethyl methacrylate (DEAEMA) and 2-Hydroxyethyl methacrylate (HEMA), crosslinked with tetraethylene glycol dimethacrylate or disulfide-crosslinker bis(2-methacryloyloxy ethyl), are synthesized. The pH-depended nanogel swelling facilitates siRNA loading and endosomal disruption. The disulfide-crosslinker ensures siRNA release by GSH-mediated particle disassociating. The nanogels are within the sub-100nm range in their collapsed state, have a PDI ≥0.4, and a ζ-potential ranging from approximately 5-10 in the swollen state and 22–30V in the collapsed state and have a swelling ratio up to 1.6 in diameter. Furthermore, the nanogels show good serum-stability, and are capable of delivering siRNA with acceptable cytotoxicity levels. The nanogels induced >90% eGFP-silencing in lung cancer cells, and gene-silencing of the cancer target POLR2A led to siRNA-induced cell death in squamous carcinoma cells. The findings suggest that the nanogel-system may function as a carrier vehicle for cytoplasmic delivery of siRNA.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
